GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SP4
|
ENSG00000105866.9 | Sp4 transcription factor |
PML
|
ENSG00000140464.15 | PML nuclear body scaffold |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PML | hg19_v2_chr15_+_74287118_74287144 | -0.22 | 1.3e-03 | Click! |
SP4 | hg19_v2_chr7_+_21467642_21467671 | -0.13 | 6.4e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr20_-_23618582 | 45.27 |
ENST00000398411.1
ENST00000376925.3 |
CST3
|
cystatin C |
chr5_+_17217669 | 44.87 |
ENST00000322611.3
|
BASP1
|
brain abundant, membrane attached signal protein 1 |
chr1_-_20812690 | 42.12 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr2_-_175869936 | 38.87 |
ENST00000409900.3
|
CHN1
|
chimerin 1 |
chr11_-_12030629 | 38.33 |
ENST00000396505.2
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
chr12_-_124457257 | 36.72 |
ENST00000545891.1
|
CCDC92
|
coiled-coil domain containing 92 |
chr3_-_149688502 | 36.56 |
ENST00000481767.1
ENST00000475518.1 |
PFN2
|
profilin 2 |
chr18_-_74844727 | 35.81 |
ENST00000355994.2
ENST00000579129.1 |
MBP
|
myelin basic protein |
chr10_-_15413035 | 35.35 |
ENST00000378116.4
ENST00000455654.1 |
FAM171A1
|
family with sequence similarity 171, member A1 |
chr9_+_137979506 | 35.08 |
ENST00000539529.1
ENST00000392991.4 ENST00000371793.3 |
OLFM1
|
olfactomedin 1 |
chr2_-_175870085 | 34.87 |
ENST00000409156.3
|
CHN1
|
chimerin 1 |
chr3_-_149688655 | 33.70 |
ENST00000461930.1
ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2
|
profilin 2 |
chr19_-_19006890 | 33.66 |
ENST00000247005.6
|
GDF1
|
growth differentiation factor 1 |
chr11_-_134281812 | 33.14 |
ENST00000392580.1
ENST00000312527.4 |
B3GAT1
|
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
chr1_+_169075554 | 33.03 |
ENST00000367815.4
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr19_+_708910 | 32.48 |
ENST00000264560.7
|
PALM
|
paralemmin |
chr9_+_139873264 | 32.31 |
ENST00000446677.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
chr8_+_1922024 | 31.77 |
ENST00000320248.3
|
KBTBD11
|
kelch repeat and BTB (POZ) domain containing 11 |
chr19_+_709101 | 31.68 |
ENST00000338448.5
|
PALM
|
paralemmin |
chr19_-_19006920 | 31.26 |
ENST00000429504.2
ENST00000427170.2 |
CERS1
|
ceramide synthase 1 |
chr1_+_6845384 | 30.86 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
chr16_+_58497567 | 30.73 |
ENST00000258187.5
|
NDRG4
|
NDRG family member 4 |
chr13_-_110438914 | 30.41 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
chr20_-_50385138 | 29.62 |
ENST00000338821.5
|
ATP9A
|
ATPase, class II, type 9A |
chr20_-_62130474 | 29.54 |
ENST00000217182.3
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
chr11_-_12030905 | 28.88 |
ENST00000326932.4
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
chrX_+_153665248 | 28.76 |
ENST00000447750.2
|
GDI1
|
GDP dissociation inhibitor 1 |
chr2_+_181845298 | 27.99 |
ENST00000410062.4
|
UBE2E3
|
ubiquitin-conjugating enzyme E2E 3 |
chr12_-_118498958 | 27.21 |
ENST00000315436.3
|
WSB2
|
WD repeat and SOCS box containing 2 |
chr12_-_124457371 | 27.05 |
ENST00000238156.3
ENST00000545037.1 |
CCDC92
|
coiled-coil domain containing 92 |
chr22_-_39239987 | 27.05 |
ENST00000333039.2
|
NPTXR
|
neuronal pentraxin receptor |
chr4_+_166128735 | 25.89 |
ENST00000226725.6
|
KLHL2
|
kelch-like family member 2 |
chr15_+_80696666 | 25.57 |
ENST00000303329.4
|
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2 |
chr20_-_50384864 | 25.34 |
ENST00000311637.5
ENST00000402822.1 |
ATP9A
|
ATPase, class II, type 9A |
chr14_+_100437780 | 25.07 |
ENST00000402714.2
|
EVL
|
Enah/Vasp-like |
chr5_-_693500 | 25.03 |
ENST00000360578.5
|
TPPP
|
tubulin polymerization promoting protein |
chr6_+_107811162 | 24.83 |
ENST00000317357.5
|
SOBP
|
sine oculis binding protein homolog (Drosophila) |
chr14_-_60337684 | 24.62 |
ENST00000267484.5
|
RTN1
|
reticulon 1 |
chr2_-_224903995 | 24.23 |
ENST00000409304.1
ENST00000454956.1 ENST00000258405.4 |
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
chr7_-_158380371 | 23.84 |
ENST00000389418.4
ENST00000389416.4 |
PTPRN2
|
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
chr10_+_11060004 | 23.76 |
ENST00000542579.1
ENST00000399850.3 ENST00000417956.2 |
CELF2
|
CUGBP, Elav-like family member 2 |
chr3_-_149688896 | 23.73 |
ENST00000239940.7
|
PFN2
|
profilin 2 |
chr22_+_32340447 | 23.69 |
ENST00000248975.5
|
YWHAH
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta |
chr15_+_68871308 | 23.67 |
ENST00000261861.5
|
CORO2B
|
coronin, actin binding protein, 2B |
chr8_-_103136481 | 23.66 |
ENST00000524209.1
ENST00000517822.1 ENST00000523923.1 ENST00000521599.1 ENST00000521964.1 ENST00000311028.3 ENST00000518166.1 |
NCALD
|
neurocalcin delta |
chr6_+_17393839 | 23.61 |
ENST00000489374.1
ENST00000378990.2 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr7_-_51384451 | 23.52 |
ENST00000441453.1
ENST00000265136.7 ENST00000395542.2 ENST00000395540.2 |
COBL
|
cordon-bleu WH2 repeat protein |
chr10_-_75634326 | 23.18 |
ENST00000322635.3
ENST00000444854.2 ENST00000423381.1 ENST00000322680.3 ENST00000394762.2 |
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
chr1_+_1981890 | 23.18 |
ENST00000378567.3
ENST00000468310.1 |
PRKCZ
|
protein kinase C, zeta |
chr16_+_2039946 | 23.14 |
ENST00000248121.2
ENST00000568896.1 |
SYNGR3
|
synaptogyrin 3 |
chr13_-_45150392 | 22.91 |
ENST00000501704.2
|
TSC22D1
|
TSC22 domain family, member 1 |
chr15_+_29131103 | 22.26 |
ENST00000558402.1
ENST00000558330.1 |
APBA2
|
amyloid beta (A4) precursor protein-binding, family A, member 2 |
chr22_-_44258360 | 22.21 |
ENST00000330884.4
ENST00000249130.5 |
SULT4A1
|
sulfotransferase family 4A, member 1 |
chr8_+_26371763 | 22.18 |
ENST00000521913.1
|
DPYSL2
|
dihydropyrimidinase-like 2 |
chr17_-_1083078 | 22.13 |
ENST00000574266.1
ENST00000302538.5 |
ABR
|
active BCR-related |
chr22_+_32340481 | 21.91 |
ENST00000397492.1
|
YWHAH
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta |
chr1_-_1822495 | 21.46 |
ENST00000378609.4
|
GNB1
|
guanine nucleotide binding protein (G protein), beta polypeptide 1 |
chr7_-_158380465 | 21.40 |
ENST00000389413.3
ENST00000409483.1 |
PTPRN2
|
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
chr22_-_45636650 | 21.31 |
ENST00000336156.5
|
KIAA0930
|
KIAA0930 |
chr16_+_11762270 | 21.28 |
ENST00000329565.5
|
SNN
|
stannin |
chr12_-_123755639 | 21.23 |
ENST00000535979.1
|
CDK2AP1
|
cyclin-dependent kinase 2 associated protein 1 |
chr14_+_29236269 | 21.17 |
ENST00000313071.4
|
FOXG1
|
forkhead box G1 |
chr12_-_121734489 | 21.10 |
ENST00000412367.2
ENST00000402834.4 ENST00000404169.3 |
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta |
chr20_+_44034804 | 20.95 |
ENST00000357275.2
ENST00000372720.3 |
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
chr4_-_102268484 | 20.82 |
ENST00000394853.4
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr10_+_121485588 | 20.77 |
ENST00000361976.2
ENST00000369083.3 |
INPP5F
|
inositol polyphosphate-5-phosphatase F |
chr9_-_139922726 | 20.44 |
ENST00000265662.5
ENST00000371605.3 |
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2 |
chr20_+_44034676 | 20.39 |
ENST00000372723.3
ENST00000372722.3 |
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
chr8_-_30670053 | 20.33 |
ENST00000518564.1
|
PPP2CB
|
protein phosphatase 2, catalytic subunit, beta isozyme |
chr1_-_241520525 | 20.27 |
ENST00000366565.1
|
RGS7
|
regulator of G-protein signaling 7 |
chr11_+_46354455 | 20.20 |
ENST00000343674.6
|
DGKZ
|
diacylglycerol kinase, zeta |
chr10_+_124221036 | 20.20 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
chr15_+_68871569 | 20.16 |
ENST00000566799.1
|
CORO2B
|
coronin, actin binding protein, 2B |
chr9_+_137967366 | 20.14 |
ENST00000252854.4
|
OLFM1
|
olfactomedin 1 |
chr19_-_6502590 | 20.02 |
ENST00000264071.2
|
TUBB4A
|
tubulin, beta 4A class IVa |
chr10_-_75634219 | 20.02 |
ENST00000305762.7
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
chr6_-_3157760 | 19.70 |
ENST00000333628.3
|
TUBB2A
|
tubulin, beta 2A class IIa |
chr17_+_40118805 | 19.70 |
ENST00000591072.1
ENST00000587679.1 ENST00000393888.1 ENST00000441615.2 |
CNP
|
2',3'-cyclic nucleotide 3' phosphodiesterase |
chr16_+_56225248 | 19.69 |
ENST00000262493.6
|
GNAO1
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
chr6_-_29600832 | 19.63 |
ENST00000377016.4
ENST00000376977.3 ENST00000377034.4 |
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr10_-_75634260 | 19.57 |
ENST00000372765.1
ENST00000351293.3 |
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
chr4_-_1242764 | 19.54 |
ENST00000514210.1
ENST00000382952.3 ENST00000290921.6 |
CTBP1
|
C-terminal binding protein 1 |
chr19_-_6502304 | 19.54 |
ENST00000540257.1
ENST00000594276.1 ENST00000594075.1 ENST00000600216.1 ENST00000596926.1 |
TUBB4A
|
tubulin, beta 4A class IVa |
chr17_+_30813576 | 19.46 |
ENST00000313401.3
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
chr6_+_17393888 | 19.45 |
ENST00000493172.1
ENST00000465994.1 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr20_+_4666882 | 19.43 |
ENST00000379440.4
ENST00000430350.2 |
PRNP
|
prion protein |
chr6_-_46459099 | 19.38 |
ENST00000371374.1
|
RCAN2
|
regulator of calcineurin 2 |
chr7_+_149571045 | 19.36 |
ENST00000479613.1
ENST00000606024.1 ENST00000464662.1 ENST00000425642.2 |
ATP6V0E2
|
ATPase, H+ transporting V0 subunit e2 |
chr20_+_11871433 | 19.31 |
ENST00000399006.2
ENST00000405977.1 |
BTBD3
|
BTB (POZ) domain containing 3 |
chr7_-_30029574 | 19.29 |
ENST00000426154.1
ENST00000421434.1 ENST00000434476.2 |
SCRN1
|
secernin 1 |
chr11_-_9286921 | 19.22 |
ENST00000328194.3
|
DENND5A
|
DENN/MADD domain containing 5A |
chr17_-_42992856 | 19.17 |
ENST00000588316.1
ENST00000435360.2 ENST00000586793.1 ENST00000588735.1 ENST00000588037.1 ENST00000592320.1 ENST00000253408.5 |
GFAP
|
glial fibrillary acidic protein |
chr7_-_38671098 | 19.12 |
ENST00000356264.2
|
AMPH
|
amphiphysin |
chr7_-_38670957 | 19.10 |
ENST00000325590.5
ENST00000428293.2 |
AMPH
|
amphiphysin |
chr8_-_18871159 | 19.05 |
ENST00000327040.8
ENST00000440756.2 |
PSD3
|
pleckstrin and Sec7 domain containing 3 |
chr1_-_32229934 | 18.98 |
ENST00000398542.1
|
BAI2
|
brain-specific angiogenesis inhibitor 2 |
chr2_-_235405679 | 18.95 |
ENST00000390645.2
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chrX_-_13956737 | 18.87 |
ENST00000454189.2
|
GPM6B
|
glycoprotein M6B |
chr4_+_6784401 | 18.86 |
ENST00000425103.1
ENST00000307659.5 |
KIAA0232
|
KIAA0232 |
chr1_-_9884011 | 18.78 |
ENST00000361311.4
|
CLSTN1
|
calsyntenin 1 |
chr12_+_7023735 | 18.65 |
ENST00000538763.1
ENST00000544774.1 ENST00000545045.2 |
ENO2
|
enolase 2 (gamma, neuronal) |
chr1_+_77747656 | 18.54 |
ENST00000354567.2
|
AK5
|
adenylate kinase 5 |
chr12_+_7023491 | 18.44 |
ENST00000541477.1
ENST00000229277.1 |
ENO2
|
enolase 2 (gamma, neuronal) |
chr14_-_74181106 | 18.42 |
ENST00000316836.3
|
PNMA1
|
paraneoplastic Ma antigen 1 |
chr16_+_2563871 | 18.41 |
ENST00000330398.4
ENST00000568562.1 ENST00000569317.1 |
ATP6V0C
ATP6C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c Uncharacterized protein |
chr14_-_65438865 | 18.38 |
ENST00000267512.5
|
RAB15
|
RAB15, member RAS oncogene family |
chr20_+_10199468 | 18.33 |
ENST00000254976.2
ENST00000304886.2 |
SNAP25
|
synaptosomal-associated protein, 25kDa |
chr13_+_98086445 | 18.32 |
ENST00000245304.4
|
RAP2A
|
RAP2A, member of RAS oncogene family |
chr1_-_241520385 | 18.31 |
ENST00000366564.1
|
RGS7
|
regulator of G-protein signaling 7 |
chr17_+_40118759 | 18.10 |
ENST00000393892.3
|
CNP
|
2',3'-cyclic nucleotide 3' phosphodiesterase |
chr1_+_171810606 | 18.00 |
ENST00000358155.4
ENST00000367733.2 ENST00000355305.5 ENST00000367731.1 |
DNM3
|
dynamin 3 |
chr13_-_36705425 | 17.96 |
ENST00000255448.4
ENST00000360631.3 ENST00000379892.4 |
DCLK1
|
doublecortin-like kinase 1 |
chr1_-_32229523 | 17.95 |
ENST00000398547.1
ENST00000373655.2 ENST00000373658.3 ENST00000257070.4 |
BAI2
|
brain-specific angiogenesis inhibitor 2 |
chr16_+_85061367 | 17.92 |
ENST00000538274.1
ENST00000258180.3 |
KIAA0513
|
KIAA0513 |
chr7_-_44365020 | 17.89 |
ENST00000395747.2
ENST00000347193.4 ENST00000346990.4 ENST00000258682.6 ENST00000353625.4 ENST00000421607.1 ENST00000424197.1 ENST00000502837.2 ENST00000350811.3 ENST00000395749.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
chr8_+_104152922 | 17.85 |
ENST00000309982.5
ENST00000438105.2 ENST00000297574.6 |
BAALC
|
brain and acute leukemia, cytoplasmic |
chr4_-_102267953 | 17.83 |
ENST00000523694.2
ENST00000507176.1 |
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr22_-_38851205 | 17.74 |
ENST00000303592.3
|
KCNJ4
|
potassium inwardly-rectifying channel, subfamily J, member 4 |
chr17_-_80656528 | 17.70 |
ENST00000538809.2
ENST00000269347.6 ENST00000571995.1 |
RAB40B
|
RAB40B, member RAS oncogene family |
chr16_+_56623433 | 17.68 |
ENST00000570176.1
|
MT3
|
metallothionein 3 |
chr3_+_11034403 | 17.65 |
ENST00000287766.4
ENST00000425938.1 |
SLC6A1
|
solute carrier family 6 (neurotransmitter transporter), member 1 |
chr4_+_2845547 | 17.64 |
ENST00000264758.7
ENST00000446856.1 ENST00000398125.1 |
ADD1
|
adducin 1 (alpha) |
chr7_-_994302 | 17.59 |
ENST00000265846.5
|
ADAP1
|
ArfGAP with dual PH domains 1 |
chr20_+_57466461 | 17.50 |
ENST00000306090.10
|
GNAS
|
GNAS complex locus |
chr7_-_766879 | 17.43 |
ENST00000537384.1
ENST00000417852.1 |
PRKAR1B
|
protein kinase, cAMP-dependent, regulatory, type I, beta |
chr4_-_102268628 | 17.41 |
ENST00000323055.6
ENST00000512215.1 ENST00000394854.3 |
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr17_-_79139817 | 17.35 |
ENST00000326724.4
|
AATK
|
apoptosis-associated tyrosine kinase |
chr17_-_8066250 | 17.33 |
ENST00000488857.1
ENST00000481878.1 ENST00000316509.6 ENST00000498285.1 |
VAMP2
RP11-599B13.6
|
vesicle-associated membrane protein 2 (synaptobrevin 2) Uncharacterized protein |
chr19_+_36359341 | 17.31 |
ENST00000221891.4
|
APLP1
|
amyloid beta (A4) precursor-like protein 1 |
chr4_-_17513851 | 17.30 |
ENST00000281243.5
|
QDPR
|
quinoid dihydropteridine reductase |
chr1_-_226924980 | 17.27 |
ENST00000272117.3
|
ITPKB
|
inositol-trisphosphate 3-kinase B |
chr14_-_21493649 | 17.23 |
ENST00000553442.1
ENST00000555869.1 ENST00000556457.1 ENST00000397844.2 ENST00000554415.1 |
NDRG2
|
NDRG family member 2 |
chr9_+_17579084 | 17.17 |
ENST00000380607.4
|
SH3GL2
|
SH3-domain GRB2-like 2 |
chr12_-_112819896 | 17.03 |
ENST00000377560.5
ENST00000430131.2 ENST00000550722.1 ENST00000550724.1 |
HECTD4
|
HECT domain containing E3 ubiquitin protein ligase 4 |
chr19_+_54926621 | 16.98 |
ENST00000376530.3
ENST00000445095.1 ENST00000391739.3 ENST00000376531.3 |
TTYH1
|
tweety family member 1 |
chr5_-_132112907 | 16.97 |
ENST00000458488.2
|
SEPT8
|
septin 8 |
chr1_-_230561475 | 16.94 |
ENST00000391860.1
|
PGBD5
|
piggyBac transposable element derived 5 |
chr20_+_57466357 | 16.79 |
ENST00000371095.3
ENST00000371085.3 ENST00000354359.7 ENST00000265620.7 |
GNAS
|
GNAS complex locus |
chr5_-_11904152 | 16.66 |
ENST00000304623.8
ENST00000458100.2 |
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
chr20_+_44035200 | 16.65 |
ENST00000372717.1
ENST00000360981.4 |
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
chr9_+_131314859 | 16.63 |
ENST00000358161.5
ENST00000372731.4 ENST00000372739.3 |
SPTAN1
|
spectrin, alpha, non-erythrocytic 1 |
chr11_+_121322832 | 16.62 |
ENST00000260197.7
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
chr9_+_129089088 | 16.61 |
ENST00000361171.3
ENST00000545391.1 |
MVB12B
|
multivesicular body subunit 12B |
chr20_+_34742650 | 16.60 |
ENST00000373945.1
ENST00000338074.2 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr5_-_132112921 | 16.56 |
ENST00000378721.4
ENST00000378701.1 |
SEPT8
|
septin 8 |
chr14_-_103987679 | 16.54 |
ENST00000553610.1
|
CKB
|
creatine kinase, brain |
chrX_-_92928557 | 16.53 |
ENST00000373079.3
ENST00000475430.2 |
NAP1L3
|
nucleosome assembly protein 1-like 3 |
chr14_+_105781048 | 16.41 |
ENST00000458164.2
ENST00000447393.1 |
PACS2
|
phosphofurin acidic cluster sorting protein 2 |
chr14_+_100150622 | 16.41 |
ENST00000261835.3
|
CYP46A1
|
cytochrome P450, family 46, subfamily A, polypeptide 1 |
chr7_+_153749732 | 16.38 |
ENST00000377770.3
|
DPP6
|
dipeptidyl-peptidase 6 |
chr14_-_93581615 | 16.36 |
ENST00000555553.1
ENST00000555495.1 ENST00000554999.1 |
ITPK1
|
inositol-tetrakisphosphate 1-kinase |
chr2_+_10442993 | 16.30 |
ENST00000423674.1
ENST00000307845.3 |
HPCAL1
|
hippocalcin-like 1 |
chr2_-_242447962 | 16.27 |
ENST00000405883.3
|
STK25
|
serine/threonine kinase 25 |
chr8_-_80680078 | 16.21 |
ENST00000337919.5
ENST00000354724.3 |
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1 |
chr5_-_11904100 | 16.19 |
ENST00000359640.2
|
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
chr20_+_43514320 | 16.18 |
ENST00000372839.3
ENST00000428262.1 ENST00000445830.1 |
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta |
chr5_-_179499108 | 16.16 |
ENST00000521389.1
|
RNF130
|
ring finger protein 130 |
chr8_+_26435359 | 16.02 |
ENST00000311151.5
|
DPYSL2
|
dihydropyrimidinase-like 2 |
chr19_-_3700388 | 15.99 |
ENST00000589578.1
ENST00000537021.1 ENST00000539785.1 ENST00000335312.3 |
PIP5K1C
|
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma |
chr9_-_139922631 | 15.95 |
ENST00000341511.6
|
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2 |
chr9_-_111929560 | 15.93 |
ENST00000561981.2
|
FRRS1L
|
ferric-chelate reductase 1-like |
chr14_-_93651186 | 15.92 |
ENST00000556883.1
ENST00000298894.4 |
MOAP1
|
modulator of apoptosis 1 |
chr14_+_104029278 | 15.87 |
ENST00000472726.2
ENST00000409074.2 ENST00000440963.1 ENST00000556253.2 ENST00000247618.4 |
RP11-73M18.2
APOPT1
|
Kinesin light chain 1 apoptogenic 1, mitochondrial |
chr11_-_65686496 | 15.86 |
ENST00000449692.3
|
C11orf68
|
chromosome 11 open reading frame 68 |
chrX_-_13956497 | 15.83 |
ENST00000398361.3
|
GPM6B
|
glycoprotein M6B |
chr1_-_11714700 | 15.78 |
ENST00000354287.4
|
FBXO2
|
F-box protein 2 |
chr18_-_74844713 | 15.74 |
ENST00000397860.3
|
MBP
|
myelin basic protein |
chr2_+_236402669 | 15.73 |
ENST00000409457.1
ENST00000336665.5 ENST00000304032.8 |
AGAP1
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
chr3_-_183543301 | 15.73 |
ENST00000318631.3
ENST00000431348.1 |
MAP6D1
|
MAP6 domain containing 1 |
chr19_-_1885432 | 15.66 |
ENST00000250974.9
|
ABHD17A
|
abhydrolase domain containing 17A |
chr1_-_17338267 | 15.65 |
ENST00000326735.8
|
ATP13A2
|
ATPase type 13A2 |
chr11_-_119293872 | 15.63 |
ENST00000524970.1
|
THY1
|
Thy-1 cell surface antigen |
chr11_-_78128811 | 15.61 |
ENST00000530915.1
ENST00000361507.4 |
GAB2
|
GRB2-associated binding protein 2 |
chr16_+_14165160 | 15.57 |
ENST00000574998.1
ENST00000571589.1 ENST00000574045.1 |
MKL2
|
MKL/myocardin-like 2 |
chr16_+_23847339 | 15.44 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
chr2_+_231729615 | 15.43 |
ENST00000326427.6
ENST00000335005.6 ENST00000326407.6 |
ITM2C
|
integral membrane protein 2C |
chr7_-_73133959 | 15.39 |
ENST00000395155.3
ENST00000395154.3 ENST00000222812.3 ENST00000395156.3 |
STX1A
|
syntaxin 1A (brain) |
chr11_-_65686586 | 15.25 |
ENST00000438576.2
|
C11orf68
|
chromosome 11 open reading frame 68 |
chr11_+_129939811 | 15.25 |
ENST00000345598.5
ENST00000338167.5 |
APLP2
|
amyloid beta (A4) precursor-like protein 2 |
chr10_+_11207438 | 15.22 |
ENST00000609692.1
ENST00000354897.3 |
CELF2
|
CUGBP, Elav-like family member 2 |
chr9_-_131790550 | 15.21 |
ENST00000372554.4
ENST00000372564.3 |
SH3GLB2
|
SH3-domain GRB2-like endophilin B2 |
chr1_-_85930823 | 15.16 |
ENST00000284031.8
ENST00000539042.1 |
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
chr22_-_39151947 | 15.14 |
ENST00000216064.4
|
SUN2
|
Sad1 and UNC84 domain containing 2 |
chr11_-_125366089 | 15.12 |
ENST00000366139.3
ENST00000278919.3 |
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
chr13_+_42031679 | 15.05 |
ENST00000379359.3
|
RGCC
|
regulator of cell cycle |
chr14_+_104095514 | 15.02 |
ENST00000348520.6
ENST00000380038.3 ENST00000389744.4 ENST00000557575.1 ENST00000553286.1 ENST00000347839.6 ENST00000555836.1 ENST00000334553.6 ENST00000246489.7 ENST00000557450.1 ENST00000452929.2 ENST00000554280.1 ENST00000445352.4 |
KLC1
|
kinesin light chain 1 |
chr16_+_2564254 | 15.00 |
ENST00000565223.1
|
ATP6V0C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c |
chr7_-_143059780 | 14.91 |
ENST00000409578.1
ENST00000409346.1 |
FAM131B
|
family with sequence similarity 131, member B |
chr2_-_242447983 | 14.85 |
ENST00000426941.1
ENST00000405585.1 ENST00000420551.1 ENST00000535007.1 ENST00000429279.1 ENST00000442307.1 ENST00000403346.3 ENST00000316586.4 |
STK25
|
serine/threonine kinase 25 |
chr6_-_84418860 | 14.82 |
ENST00000521743.1
|
SNAP91
|
synaptosomal-associated protein, 91kDa |
chr9_-_101471479 | 14.77 |
ENST00000259455.2
|
GABBR2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
chr9_-_131790464 | 14.76 |
ENST00000417224.1
ENST00000416629.1 ENST00000372559.1 |
SH3GLB2
|
SH3-domain GRB2-like endophilin B2 |
chr3_-_18466787 | 14.76 |
ENST00000338745.6
ENST00000450898.1 |
SATB1
|
SATB homeobox 1 |
chr6_-_84419101 | 14.74 |
ENST00000520302.1
ENST00000520213.1 ENST00000439399.2 ENST00000428679.2 ENST00000437520.1 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
chr16_-_66785497 | 14.70 |
ENST00000440564.2
ENST00000379482.2 ENST00000443351.2 ENST00000566150.1 |
DYNC1LI2
|
dynein, cytoplasmic 1, light intermediate chain 2 |
chr19_+_54926601 | 14.65 |
ENST00000301194.4
|
TTYH1
|
tweety family member 1 |
chr11_+_129939779 | 14.63 |
ENST00000533195.1
ENST00000533713.1 ENST00000528499.1 ENST00000539648.1 ENST00000263574.5 |
APLP2
|
amyloid beta (A4) precursor-like protein 2 |
chr16_-_57318566 | 14.60 |
ENST00000569059.1
ENST00000219207.5 |
PLLP
|
plasmolipin |
chr20_+_11871371 | 14.59 |
ENST00000254977.3
|
BTBD3
|
BTB (POZ) domain containing 3 |
chr8_+_86376081 | 14.58 |
ENST00000285379.5
|
CA2
|
carbonic anhydrase II |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.7 | 56.1 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
17.1 | 68.4 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
16.8 | 67.0 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
12.1 | 36.2 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
11.0 | 131.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
10.7 | 32.2 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
10.5 | 31.4 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
10.3 | 51.6 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
10.1 | 30.2 | GO:1905166 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
9.9 | 29.8 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
9.7 | 29.0 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
9.0 | 27.0 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
8.8 | 26.5 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
8.1 | 24.3 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
8.1 | 32.2 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
7.9 | 71.5 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
7.8 | 23.5 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
7.7 | 23.0 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
7.7 | 61.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
7.5 | 29.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
7.3 | 21.8 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
7.2 | 28.9 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
7.1 | 35.3 | GO:2001074 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
7.0 | 35.1 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
7.0 | 7.0 | GO:1902667 | regulation of axon guidance(GO:1902667) |
6.8 | 47.7 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
6.7 | 53.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
6.5 | 26.1 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
6.4 | 32.0 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
6.3 | 19.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
6.2 | 6.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
6.1 | 36.6 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
6.0 | 18.0 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
5.9 | 17.8 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
5.9 | 47.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
5.9 | 41.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
5.9 | 23.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
5.9 | 76.1 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
5.8 | 17.5 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
5.8 | 28.8 | GO:0061107 | seminal vesicle development(GO:0061107) |
5.7 | 22.7 | GO:0001757 | somite specification(GO:0001757) |
5.7 | 34.0 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
5.6 | 16.9 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
5.5 | 82.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
5.5 | 43.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
5.4 | 21.5 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
5.3 | 47.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
5.3 | 53.2 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
5.3 | 15.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
5.2 | 26.2 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
4.9 | 14.8 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
4.9 | 29.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
4.8 | 28.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
4.8 | 14.3 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
4.7 | 18.7 | GO:1904978 | regulation of endosome organization(GO:1904978) |
4.7 | 14.0 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
4.6 | 4.6 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
4.6 | 73.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
4.6 | 13.8 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
4.6 | 18.3 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
4.6 | 36.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
4.5 | 22.3 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
4.5 | 13.4 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
4.4 | 13.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
4.4 | 26.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
4.3 | 34.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
4.2 | 12.6 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
4.2 | 29.5 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
4.2 | 16.8 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
4.2 | 12.6 | GO:0042938 | dipeptide transport(GO:0042938) |
4.1 | 20.6 | GO:0035900 | response to isolation stress(GO:0035900) |
4.1 | 16.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
4.1 | 40.9 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
4.0 | 16.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
4.0 | 28.1 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
4.0 | 12.0 | GO:1904799 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
4.0 | 47.9 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
3.9 | 39.2 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
3.9 | 11.7 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
3.9 | 39.0 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
3.9 | 11.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
3.8 | 11.5 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
3.8 | 15.1 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
3.8 | 11.3 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
3.8 | 18.8 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
3.8 | 11.3 | GO:1904398 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) positive regulation of neuromuscular junction development(GO:1904398) |
3.7 | 3.7 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
3.7 | 3.7 | GO:0070142 | synaptic vesicle budding(GO:0070142) |
3.7 | 11.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
3.7 | 70.0 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
3.7 | 25.7 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
3.6 | 43.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
3.6 | 29.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
3.6 | 14.5 | GO:0097338 | response to clozapine(GO:0097338) |
3.6 | 25.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
3.6 | 14.3 | GO:0021564 | vagus nerve development(GO:0021564) |
3.5 | 31.9 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
3.5 | 7.1 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
3.5 | 27.8 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
3.5 | 45.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
3.4 | 6.9 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
3.4 | 17.2 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
3.4 | 24.0 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
3.4 | 54.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
3.4 | 16.8 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
3.3 | 96.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
3.3 | 16.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
3.3 | 3.3 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
3.3 | 9.9 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
3.3 | 195.6 | GO:0021762 | substantia nigra development(GO:0021762) |
3.3 | 16.3 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
3.3 | 19.5 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
3.2 | 9.7 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
3.2 | 9.7 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
3.2 | 12.6 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
3.1 | 6.2 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
3.1 | 15.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
3.0 | 24.4 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
3.0 | 9.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
3.0 | 15.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
3.0 | 24.0 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
3.0 | 9.0 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
3.0 | 11.9 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
3.0 | 5.9 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
2.9 | 61.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
2.9 | 8.8 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
2.9 | 14.6 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
2.9 | 43.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
2.9 | 14.4 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
2.8 | 11.4 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
2.8 | 11.3 | GO:0046108 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
2.8 | 8.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
2.8 | 11.1 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
2.8 | 5.5 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
2.8 | 5.5 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
2.8 | 8.3 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
2.7 | 8.1 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
2.7 | 23.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
2.7 | 21.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
2.7 | 8.0 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
2.6 | 7.9 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
2.6 | 7.9 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
2.6 | 2.6 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
2.6 | 10.5 | GO:0072660 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
2.6 | 10.5 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
2.6 | 15.7 | GO:0032252 | secretory granule localization(GO:0032252) |
2.6 | 20.9 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.6 | 5.2 | GO:1903012 | positive regulation of bone development(GO:1903012) positive regulation of osteoclast development(GO:2001206) |
2.6 | 7.8 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
2.6 | 5.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
2.6 | 38.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
2.6 | 2.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
2.6 | 20.4 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
2.6 | 7.7 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
2.5 | 22.9 | GO:0033227 | dsRNA transport(GO:0033227) |
2.5 | 10.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
2.5 | 85.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
2.5 | 12.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
2.4 | 9.8 | GO:0048102 | autophagic cell death(GO:0048102) |
2.4 | 14.6 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
2.4 | 51.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
2.4 | 7.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
2.4 | 31.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
2.4 | 9.6 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
2.4 | 2.4 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
2.4 | 7.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
2.4 | 2.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
2.4 | 2.4 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
2.4 | 7.1 | GO:1990834 | response to odorant(GO:1990834) |
2.4 | 4.7 | GO:0007412 | axon target recognition(GO:0007412) |
2.3 | 4.7 | GO:0070426 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
2.3 | 16.4 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
2.3 | 11.7 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
2.3 | 55.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
2.3 | 9.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
2.3 | 4.6 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
2.3 | 47.8 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
2.3 | 4.5 | GO:1902576 | negative regulation of nuclear cell cycle DNA replication(GO:1902576) |
2.3 | 11.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
2.3 | 6.8 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
2.3 | 18.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
2.2 | 6.7 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
2.2 | 24.7 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
2.2 | 6.7 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
2.2 | 8.9 | GO:0046502 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
2.2 | 8.9 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
2.2 | 2.2 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
2.2 | 17.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
2.2 | 6.6 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
2.2 | 6.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
2.2 | 10.9 | GO:0030070 | insulin processing(GO:0030070) |
2.2 | 13.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
2.2 | 19.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
2.2 | 15.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
2.2 | 4.3 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
2.1 | 6.4 | GO:0060437 | lung growth(GO:0060437) |
2.1 | 6.4 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
2.1 | 8.5 | GO:1902075 | cellular response to salt(GO:1902075) |
2.1 | 23.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
2.1 | 10.4 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
2.1 | 10.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
2.1 | 4.2 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
2.1 | 14.5 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
2.1 | 12.4 | GO:0046958 | nonassociative learning(GO:0046958) |
2.1 | 4.1 | GO:0021779 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
2.0 | 24.6 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
2.0 | 36.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
2.0 | 18.4 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
2.0 | 12.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
2.0 | 2.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
2.0 | 2.0 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
2.0 | 2.0 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
2.0 | 33.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.9 | 3.9 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
1.9 | 13.6 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
1.9 | 33.0 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
1.9 | 7.8 | GO:0015808 | L-alanine transport(GO:0015808) |
1.9 | 7.7 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.9 | 34.7 | GO:0034389 | lipid particle organization(GO:0034389) |
1.9 | 34.6 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.9 | 15.4 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
1.9 | 23.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.9 | 1.9 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
1.9 | 9.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.9 | 7.6 | GO:0070375 | ERK5 cascade(GO:0070375) |
1.9 | 11.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.9 | 3.8 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.9 | 16.9 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.9 | 15.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.9 | 1.9 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
1.9 | 7.4 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
1.9 | 29.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
1.8 | 18.4 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
1.8 | 12.8 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
1.8 | 85.8 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
1.8 | 9.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
1.8 | 5.5 | GO:0042823 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
1.8 | 5.5 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
1.8 | 5.4 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
1.8 | 14.2 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.8 | 1.8 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
1.8 | 5.3 | GO:0060615 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
1.8 | 1.8 | GO:0010265 | SCF complex assembly(GO:0010265) |
1.8 | 5.3 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
1.7 | 14.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.7 | 1.7 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
1.7 | 7.0 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
1.7 | 17.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
1.7 | 6.8 | GO:1903416 | response to glycoside(GO:1903416) |
1.7 | 6.8 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.7 | 16.9 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
1.7 | 8.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.7 | 1.7 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.7 | 3.3 | GO:0046836 | glycolipid transport(GO:0046836) |
1.7 | 1.7 | GO:0042158 | protein lipidation(GO:0006497) lipoprotein biosynthetic process(GO:0042158) |
1.7 | 3.3 | GO:1904815 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
1.6 | 8.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
1.6 | 3.3 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
1.6 | 4.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.6 | 6.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.6 | 9.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
1.6 | 9.6 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
1.6 | 9.5 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
1.6 | 7.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
1.6 | 39.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
1.6 | 3.1 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
1.6 | 21.8 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
1.6 | 10.9 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
1.6 | 43.4 | GO:0032456 | endocytic recycling(GO:0032456) |
1.5 | 12.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.5 | 10.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
1.5 | 1.5 | GO:0051451 | myoblast migration(GO:0051451) |
1.5 | 6.1 | GO:0014040 | positive regulation of Schwann cell differentiation(GO:0014040) |
1.5 | 7.6 | GO:0035617 | stress granule disassembly(GO:0035617) |
1.5 | 1.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.5 | 1.5 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
1.5 | 3.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
1.5 | 9.0 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
1.5 | 4.5 | GO:0021592 | fourth ventricle development(GO:0021592) third ventricle development(GO:0021678) |
1.5 | 22.5 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
1.5 | 25.2 | GO:0090383 | phagosome acidification(GO:0090383) |
1.5 | 2.9 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.5 | 1.5 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
1.5 | 8.8 | GO:0090382 | phagosome maturation(GO:0090382) |
1.5 | 89.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
1.5 | 26.2 | GO:0070977 | bone maturation(GO:0070977) |
1.5 | 11.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
1.4 | 20.2 | GO:0060004 | reflex(GO:0060004) |
1.4 | 10.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
1.4 | 12.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.4 | 7.1 | GO:1901909 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
1.4 | 15.6 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
1.4 | 11.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.4 | 8.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
1.4 | 96.8 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
1.4 | 9.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
1.4 | 15.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.4 | 4.1 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
1.4 | 16.5 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
1.4 | 2.7 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
1.4 | 2.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.4 | 54.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
1.4 | 14.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
1.4 | 9.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
1.4 | 6.8 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
1.4 | 5.4 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
1.3 | 5.4 | GO:0016322 | neuron remodeling(GO:0016322) |
1.3 | 5.4 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
1.3 | 30.8 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
1.3 | 51.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
1.3 | 1.3 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
1.3 | 4.0 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
1.3 | 10.5 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
1.3 | 6.5 | GO:0003322 | pancreatic A cell development(GO:0003322) |
1.3 | 3.9 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
1.3 | 9.1 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
1.3 | 9.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
1.3 | 3.9 | GO:0051697 | protein delipidation(GO:0051697) |
1.3 | 46.7 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
1.3 | 2.6 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
1.3 | 5.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
1.3 | 5.2 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
1.3 | 1.3 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
1.3 | 2.6 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.3 | 14.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.3 | 3.8 | GO:0070842 | aggresome assembly(GO:0070842) |
1.3 | 2.5 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
1.3 | 5.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
1.3 | 8.9 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
1.3 | 10.0 | GO:0051601 | exocyst localization(GO:0051601) |
1.3 | 25.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
1.2 | 1.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.2 | 1.2 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
1.2 | 9.9 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
1.2 | 18.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.2 | 5.0 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
1.2 | 7.4 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
1.2 | 3.7 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
1.2 | 7.4 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
1.2 | 2.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
1.2 | 4.8 | GO:0030035 | microspike assembly(GO:0030035) |
1.2 | 4.8 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
1.2 | 1.2 | GO:0043084 | penile erection(GO:0043084) |
1.2 | 45.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
1.2 | 1.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.2 | 22.8 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
1.2 | 2.4 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
1.2 | 8.2 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
1.2 | 16.5 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
1.2 | 3.5 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
1.2 | 3.5 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
1.2 | 1.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.2 | 1.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.2 | 40.6 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
1.2 | 1.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.2 | 6.9 | GO:0061462 | protein localization to lysosome(GO:0061462) |
1.2 | 17.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.2 | 15.0 | GO:0071625 | vocalization behavior(GO:0071625) |
1.2 | 1.2 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.2 | 1.2 | GO:0044091 | membrane biogenesis(GO:0044091) |
1.1 | 4.6 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
1.1 | 5.7 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
1.1 | 3.4 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
1.1 | 22.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.1 | 6.8 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
1.1 | 19.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.1 | 6.8 | GO:0048243 | norepinephrine secretion(GO:0048243) |
1.1 | 14.6 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
1.1 | 9.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
1.1 | 21.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.1 | 1.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
1.1 | 1.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
1.1 | 4.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
1.1 | 2.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.1 | 6.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.1 | 6.6 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
1.1 | 13.2 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
1.1 | 7.7 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.1 | 5.5 | GO:0070560 | protein secretion by platelet(GO:0070560) |
1.1 | 6.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
1.1 | 3.3 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
1.1 | 6.5 | GO:0034214 | protein hexamerization(GO:0034214) |
1.1 | 4.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
1.1 | 4.3 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
1.1 | 11.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
1.1 | 2.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.1 | 9.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.1 | 2.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.1 | 21.3 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
1.1 | 5.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
1.1 | 5.3 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
1.1 | 2.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
1.1 | 2.1 | GO:0035419 | activation of MAPK activity involved in innate immune response(GO:0035419) |
1.0 | 7.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
1.0 | 3.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
1.0 | 5.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
1.0 | 3.1 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
1.0 | 20.6 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
1.0 | 3.1 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
1.0 | 1.0 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
1.0 | 17.3 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
1.0 | 5.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.0 | 6.1 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
1.0 | 22.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.0 | 33.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
1.0 | 4.0 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
1.0 | 3.0 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
1.0 | 98.1 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
1.0 | 12.9 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.0 | 5.0 | GO:0019640 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
1.0 | 22.8 | GO:0014003 | oligodendrocyte development(GO:0014003) |
1.0 | 7.9 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.0 | 3.9 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
1.0 | 3.9 | GO:0097320 | membrane tubulation(GO:0097320) |
1.0 | 2.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
1.0 | 1.0 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
1.0 | 36.8 | GO:0046785 | microtubule polymerization(GO:0046785) |
1.0 | 2.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.0 | 3.9 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.0 | 7.7 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
1.0 | 1.0 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
1.0 | 1.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.9 | 5.7 | GO:0005985 | sucrose metabolic process(GO:0005985) |
0.9 | 2.8 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
0.9 | 9.5 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.9 | 12.3 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.9 | 4.7 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.9 | 0.9 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.9 | 6.5 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.9 | 4.6 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.9 | 1.9 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.9 | 2.8 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
0.9 | 0.9 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.9 | 1.8 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.9 | 9.1 | GO:0098930 | anterograde axonal transport(GO:0008089) axonal transport(GO:0098930) |
0.9 | 5.5 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.9 | 5.4 | GO:0051012 | microtubule sliding(GO:0051012) |
0.9 | 41.6 | GO:0046847 | filopodium assembly(GO:0046847) |
0.9 | 4.5 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.9 | 0.9 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.9 | 1.8 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.9 | 10.6 | GO:0001881 | receptor recycling(GO:0001881) |
0.9 | 1.8 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.9 | 3.5 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.9 | 0.9 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.9 | 7.0 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.9 | 27.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.9 | 3.5 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.9 | 9.5 | GO:0032438 | melanosome organization(GO:0032438) |
0.9 | 2.6 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.9 | 2.6 | GO:0002880 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.9 | 0.9 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.9 | 2.6 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.9 | 2.6 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) |
0.8 | 1.7 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.8 | 7.6 | GO:0030091 | protein repair(GO:0030091) |
0.8 | 4.2 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.8 | 1.7 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.8 | 5.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.8 | 1.7 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
0.8 | 3.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.8 | 3.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.8 | 0.8 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.8 | 15.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.8 | 3.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.8 | 28.4 | GO:0007041 | lysosomal transport(GO:0007041) |
0.8 | 36.5 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.8 | 21.5 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.8 | 2.5 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.8 | 1.6 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.8 | 5.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.8 | 1.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.8 | 7.3 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.8 | 0.8 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.8 | 2.4 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.8 | 1.6 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.8 | 5.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.8 | 7.2 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.8 | 0.8 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.8 | 2.4 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.8 | 5.5 | GO:0070459 | prolactin secretion(GO:0070459) |
0.8 | 0.8 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) |
0.8 | 2.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.8 | 10.3 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.8 | 1.6 | GO:0030242 | pexophagy(GO:0030242) |
0.8 | 0.8 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.8 | 7.0 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.8 | 4.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.8 | 3.1 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.8 | 0.8 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.8 | 4.6 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.8 | 1.5 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.8 | 9.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.8 | 7.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.8 | 3.0 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.8 | 1.5 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.8 | 3.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.8 | 45.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.7 | 7.5 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.7 | 6.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.7 | 2.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.7 | 2.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.7 | 0.7 | GO:1903909 | regulation of receptor clustering(GO:1903909) |
0.7 | 2.9 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.7 | 7.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.7 | 5.0 | GO:0030497 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
0.7 | 2.9 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.7 | 4.3 | GO:0015853 | adenine transport(GO:0015853) |
0.7 | 3.6 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.7 | 5.0 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.7 | 1.4 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.7 | 2.8 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.7 | 0.7 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.7 | 6.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.7 | 9.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.7 | 1.4 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.7 | 1.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.7 | 5.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.7 | 1.4 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.7 | 3.5 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.7 | 25.5 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.7 | 4.1 | GO:0032472 | Golgi calcium ion homeostasis(GO:0032468) Golgi calcium ion transport(GO:0032472) |
0.7 | 3.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.7 | 2.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.7 | 2.0 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.7 | 2.7 | GO:0031179 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
0.7 | 2.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.7 | 5.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.7 | 2.0 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.7 | 2.7 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.7 | 1.3 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.7 | 19.7 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.7 | 7.9 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.7 | 1.3 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.7 | 7.8 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.7 | 1.3 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.6 | 2.6 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.6 | 0.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.6 | 3.2 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) cell migration involved in kidney development(GO:0035787) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) negative regulation of phospholipid biosynthetic process(GO:0071072) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.6 | 1.9 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.6 | 1.9 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.6 | 1.9 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.6 | 10.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.6 | 3.8 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.6 | 7.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.6 | 3.1 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.6 | 21.1 | GO:0035307 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
0.6 | 0.6 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.6 | 2.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.6 | 0.6 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.6 | 1.2 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) response to host(GO:0075136) |
0.6 | 1.8 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.6 | 6.7 | GO:0015886 | heme transport(GO:0015886) |
0.6 | 2.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.6 | 1.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.6 | 2.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.6 | 0.6 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.6 | 3.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.6 | 1.8 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.6 | 2.4 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.6 | 2.4 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.6 | 6.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.6 | 1.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.6 | 3.6 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.6 | 3.0 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.6 | 1.2 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.6 | 2.4 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.6 | 0.6 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.6 | 10.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.6 | 3.5 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.6 | 1.2 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.6 | 5.3 | GO:0032264 | IMP salvage(GO:0032264) |
0.6 | 0.6 | GO:2000467 | regulation of glycogen (starch) synthase activity(GO:2000465) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.6 | 1.7 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.6 | 2.9 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
0.6 | 0.6 | GO:0045404 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.6 | 2.9 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.6 | 2.9 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.6 | 5.1 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.6 | 2.8 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.6 | 2.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.6 | 1.7 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.6 | 7.8 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.6 | 0.6 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.6 | 1.1 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.6 | 2.2 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.6 | 7.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.6 | 19.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.5 | 1.6 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.5 | 8.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.5 | 3.2 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.5 | 1.1 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.5 | 3.2 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.5 | 1.6 | GO:0002818 | intracellular defense response(GO:0002818) |
0.5 | 2.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.5 | 4.8 | GO:0046689 | response to mercury ion(GO:0046689) |
0.5 | 1.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.5 | 1.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.5 | 20.0 | GO:0090102 | cochlea development(GO:0090102) |
0.5 | 0.5 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.5 | 1.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.5 | 0.5 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.5 | 2.6 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.5 | 4.1 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.5 | 2.0 | GO:0080009 | mRNA methylation(GO:0080009) |
0.5 | 6.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 2.5 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.5 | 3.0 | GO:0009650 | UV protection(GO:0009650) |
0.5 | 5.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.5 | 2.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.5 | 5.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.5 | 30.8 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.5 | 0.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.5 | 5.9 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.5 | 12.4 | GO:0051693 | actin filament capping(GO:0051693) |
0.5 | 3.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.5 | 1.0 | GO:0051029 | rRNA transport(GO:0051029) |
0.5 | 10.3 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.5 | 1.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.5 | 7.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.5 | 1.0 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.5 | 0.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.5 | 4.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.5 | 5.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.5 | 23.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.5 | 1.0 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.5 | 0.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.5 | 3.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.5 | 1.9 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.5 | 2.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.5 | 0.5 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.5 | 0.5 | GO:0010935 | macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) |
0.5 | 1.4 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
0.5 | 4.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.5 | 13.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.5 | 0.5 | GO:0015846 | polyamine transport(GO:0015846) |
0.5 | 0.9 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.5 | 2.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.5 | 4.1 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.5 | 0.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.5 | 5.9 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.5 | 3.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.5 | 1.8 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.5 | 16.7 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.4 | 0.9 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.4 | 2.7 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.4 | 3.6 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.4 | 4.5 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.4 | 4.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.4 | 1.3 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.4 | 2.7 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.4 | 9.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.4 | 2.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.4 | 2.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.4 | 3.0 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.4 | 0.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.4 | 7.0 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.4 | 8.7 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.4 | 0.9 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.4 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.4 | 0.4 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.4 | 0.4 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.4 | 1.3 | GO:0042756 | drinking behavior(GO:0042756) |
0.4 | 0.8 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.4 | 0.4 | GO:0060157 | urinary bladder development(GO:0060157) |
0.4 | 0.8 | GO:0043486 | histone exchange(GO:0043486) |
0.4 | 5.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.4 | 2.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.4 | 1.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.4 | 4.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.4 | 1.2 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.4 | 1.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.4 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.4 | 3.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.4 | 0.8 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.4 | 0.4 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
0.4 | 2.0 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.4 | 7.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 2.8 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.4 | 0.4 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.4 | 0.4 | GO:1900368 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
0.4 | 3.2 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.4 | 1.2 | GO:0046463 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.4 | 0.8 | GO:0055099 | detection of endogenous stimulus(GO:0009726) response to high density lipoprotein particle(GO:0055099) |
0.4 | 1.6 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.4 | 5.1 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.4 | 1.9 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.4 | 1.2 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.4 | 0.4 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
0.4 | 2.3 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.4 | 9.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.4 | 1.9 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.4 | 0.8 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.4 | 2.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.4 | 3.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 3.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.4 | 2.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 1.9 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.4 | 0.4 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.4 | 1.1 | GO:0008306 | associative learning(GO:0008306) |
0.4 | 3.0 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.4 | 0.4 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.4 | 1.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 10.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 1.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.4 | 1.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.4 | 1.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.4 | 0.7 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.3 | 7.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.3 | 1.4 | GO:0009414 | response to water deprivation(GO:0009414) |
0.3 | 1.4 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.3 | 1.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.3 | 6.2 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.3 | 0.3 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.3 | 2.4 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 7.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 5.8 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.3 | 0.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 1.0 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.3 | 1.0 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.3 | 11.3 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.3 | 1.0 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.3 | 2.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 0.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 0.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 1.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 1.0 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.3 | 0.7 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.3 | 0.3 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) dATP catabolic process(GO:0046061) |
0.3 | 11.6 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.3 | 4.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.3 | 0.6 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
0.3 | 0.6 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.3 | 3.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 0.6 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.3 | 0.9 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.3 | 2.2 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.3 | 6.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 0.3 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.3 | 0.6 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.3 | 0.6 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.3 | 0.6 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.3 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 0.3 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.3 | 6.3 | GO:0008542 | visual learning(GO:0008542) |
0.3 | 1.2 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
0.3 | 1.2 | GO:0046618 | drug export(GO:0046618) |
0.3 | 0.6 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.3 | 0.3 | GO:0044362 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.3 | 1.8 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 0.9 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.3 | 0.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 0.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.3 | 1.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 2.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.3 | 0.3 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.3 | 1.4 | GO:0006574 | valine catabolic process(GO:0006574) |
0.3 | 1.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.3 | 2.0 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.3 | 1.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.3 | 0.3 | GO:0097484 | dendrite extension(GO:0097484) |
0.3 | 2.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 1.1 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.3 | 5.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 1.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 1.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 0.6 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.3 | 0.3 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.3 | 0.6 | GO:0002384 | hepatic immune response(GO:0002384) |
0.3 | 0.3 | GO:2000366 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
0.3 | 0.8 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.3 | 1.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.3 | 6.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.3 | 1.8 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.3 | 1.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 3.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 1.0 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 9.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 2.6 | GO:0035640 | exploration behavior(GO:0035640) |
0.3 | 0.8 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 3.8 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.3 | 0.5 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.3 | 4.3 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.3 | 3.3 | GO:0097178 | ruffle assembly(GO:0097178) |
0.3 | 0.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 1.0 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.3 | 0.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 0.5 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 0.5 | GO:0061245 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.3 | 0.5 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.2 | 2.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 1.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 0.7 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.2 | 0.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 2.9 | GO:0034776 | response to histamine(GO:0034776) |
0.2 | 1.0 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.2 | 2.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 1.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.2 | GO:1905031 | regulation of potassium ion export across plasma membrane(GO:1903764) regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905031) |
0.2 | 0.5 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 12.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 4.4 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 6.5 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 10.6 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.2 | 2.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 5.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.2 | 0.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 5.9 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.2 | 0.2 | GO:0043335 | protein unfolding(GO:0043335) |
0.2 | 3.8 | GO:0014889 | muscle atrophy(GO:0014889) |
0.2 | 1.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.4 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.2 | 1.3 | GO:0042426 | choline catabolic process(GO:0042426) |
0.2 | 4.1 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.2 | 0.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.2 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
0.2 | 2.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 9.3 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.2 | 2.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 1.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 0.4 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 1.8 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 1.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 2.2 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.2 | 0.2 | GO:0090427 | activation of meiosis(GO:0090427) |
0.2 | 0.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.2 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 1.5 | GO:0051924 | regulation of calcium ion transport(GO:0051924) |
0.2 | 11.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 0.6 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.2 | 0.8 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 1.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 0.6 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
0.2 | 0.4 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.2 | 0.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.7 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.2 | 1.1 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.2 | 0.9 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.9 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 0.2 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.2 | 2.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 0.9 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.2 | 3.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 9.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 2.5 | GO:0032418 | lysosome localization(GO:0032418) |
0.2 | 1.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 0.5 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.2 | 0.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 2.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.7 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
0.2 | 0.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 1.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.2 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 3.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.8 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.2 | 1.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.3 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.2 | 0.2 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
0.2 | 0.5 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.2 | 0.6 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
0.2 | 0.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 1.8 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) |
0.1 | 0.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 1.6 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.1 | 2.8 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
0.1 | 0.3 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.1 | 0.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.4 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.9 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 2.8 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.1 | 0.6 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.3 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.9 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.1 | 2.6 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.8 | GO:0090196 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) |
0.1 | 0.6 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.1 | 0.7 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 2.5 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 2.3 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 2.2 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.1 | 0.5 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) malonyl-CoA biosynthetic process(GO:2001295) |
0.1 | 0.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 1.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 37.9 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.8 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.1 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.1 | 0.3 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.1 | 0.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.4 | GO:0070781 | response to biotin(GO:0070781) |
0.1 | 0.4 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 4.5 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.3 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 3.0 | GO:0046323 | glucose import(GO:0046323) |
0.1 | 1.0 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.2 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.1 | 1.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.4 | GO:0045957 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
0.1 | 2.2 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 1.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.1 | GO:0030431 | sleep(GO:0030431) |
0.1 | 1.0 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.2 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.1 | 0.5 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 1.2 | GO:0044070 | regulation of anion transport(GO:0044070) |
0.1 | 2.6 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.2 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
0.1 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.1 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
0.1 | 0.2 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.1 | 1.5 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 4.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.4 | GO:0048749 | compound eye development(GO:0048749) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.1 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.1 | 0.3 | GO:0045073 | regulation of chemokine biosynthetic process(GO:0045073) |
0.1 | 4.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 1.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.3 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.4 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 1.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.1 | GO:2000667 | positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.1 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
0.1 | 0.1 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.4 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.1 | 0.3 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.3 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.4 | GO:0043382 | regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) |
0.1 | 0.6 | GO:0030837 | negative regulation of actin filament polymerization(GO:0030837) |
0.1 | 0.3 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.1 | 0.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.5 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 0.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 0.3 | GO:0060697 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) positive regulation of phospholipid catabolic process(GO:0060697) |
0.1 | 0.3 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.7 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.6 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.3 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 33.6 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.1 | 0.7 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.4 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 1.2 | GO:0097502 | mannosylation(GO:0097502) |
0.1 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.5 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 0.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.4 | GO:0015827 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) tryptophan transport(GO:0015827) leucine import(GO:0060356) |
0.1 | 0.1 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.1 | 0.9 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.1 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.1 | 0.2 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.1 | 2.9 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.2 | GO:0051039 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.1 | 0.1 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.1 | 0.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.4 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.1 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.2 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.1 | 0.1 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.1 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 0.2 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.6 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.1 | 0.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.2 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.1 | 0.2 | GO:0050779 | RNA destabilization(GO:0050779) |
0.1 | 0.2 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 1.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.1 | GO:0032095 | regulation of response to food(GO:0032095) |
0.1 | 0.2 | GO:1901626 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) regulation of postsynaptic membrane organization(GO:1901626) |
0.1 | 0.1 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.1 | 0.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 0.2 | GO:0097480 | synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
0.1 | 1.1 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.1 | 0.1 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.1 | 0.7 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.1 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.6 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.2 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 4.8 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.0 | 0.0 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.0 | 0.0 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.2 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.2 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.0 | 0.3 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.0 | 0.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.3 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.0 | 0.5 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.1 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
0.0 | 0.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.0 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.1 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.0 | 0.9 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.2 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.0 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.1 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 1.0 | GO:0055074 | calcium ion homeostasis(GO:0055074) |
0.0 | 0.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
0.0 | 0.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.1 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
0.0 | 0.0 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.0 | 0.1 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0048679 | regulation of axon regeneration(GO:0048679) |
0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.0 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.0 | GO:0045345 | positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.0 | 0.1 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.1 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.0 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
0.0 | 0.0 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.7 | 58.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
12.7 | 38.0 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
11.7 | 81.9 | GO:0033269 | internode region of axon(GO:0033269) |
8.6 | 42.8 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
8.2 | 32.9 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
7.3 | 21.9 | GO:0019034 | viral replication complex(GO:0019034) |
7.1 | 42.4 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
6.6 | 59.1 | GO:0005955 | calcineurin complex(GO:0005955) |
6.3 | 37.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
6.2 | 24.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
5.9 | 23.7 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
5.2 | 20.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
5.1 | 107.3 | GO:0044295 | axonal growth cone(GO:0044295) |
4.9 | 34.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
4.7 | 14.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
4.7 | 18.8 | GO:0042995 | cell projection(GO:0042995) |
4.6 | 4.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
4.6 | 13.9 | GO:0016938 | kinesin I complex(GO:0016938) |
4.6 | 64.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
4.5 | 18.2 | GO:0031673 | H zone(GO:0031673) |
4.4 | 13.3 | GO:0043291 | RAVE complex(GO:0043291) |
4.2 | 84.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
4.2 | 25.1 | GO:0044327 | dendritic spine head(GO:0044327) |
4.1 | 20.5 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
4.0 | 24.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
3.9 | 66.4 | GO:0097386 | glial cell projection(GO:0097386) |
3.8 | 11.5 | GO:0072534 | perineuronal net(GO:0072534) |
3.8 | 30.4 | GO:0098845 | postsynaptic endosome(GO:0098845) |
3.7 | 47.9 | GO:0097433 | dense body(GO:0097433) |
3.7 | 11.0 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
3.5 | 78.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
3.5 | 45.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
3.4 | 24.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
3.4 | 44.5 | GO:0097470 | ribbon synapse(GO:0097470) |
3.4 | 40.9 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
3.4 | 33.8 | GO:0045180 | basal cortex(GO:0045180) |
3.4 | 26.9 | GO:0045179 | apical cortex(GO:0045179) |
3.4 | 6.7 | GO:0014802 | terminal cisterna(GO:0014802) |
3.3 | 9.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
3.2 | 15.9 | GO:0045298 | tubulin complex(GO:0045298) |
3.2 | 170.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
3.1 | 25.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
3.1 | 21.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
3.0 | 48.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
3.0 | 75.2 | GO:0031143 | pseudopodium(GO:0031143) |
3.0 | 35.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
3.0 | 23.6 | GO:0035976 | AP1 complex(GO:0035976) |
2.9 | 242.0 | GO:0043195 | terminal bouton(GO:0043195) |
2.8 | 27.8 | GO:0097427 | microtubule bundle(GO:0097427) |
2.8 | 41.3 | GO:0043194 | axon initial segment(GO:0043194) |
2.7 | 40.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
2.7 | 10.7 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
2.6 | 26.0 | GO:0005875 | microtubule associated complex(GO:0005875) |
2.5 | 33.0 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
2.5 | 35.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
2.5 | 22.2 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.4 | 12.2 | GO:0042583 | chromaffin granule(GO:0042583) |
2.4 | 9.7 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
2.4 | 72.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
2.4 | 7.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
2.3 | 16.4 | GO:0036021 | endolysosome lumen(GO:0036021) |
2.2 | 100.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
2.2 | 6.6 | GO:0000806 | Y chromosome(GO:0000806) |
2.2 | 36.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
2.2 | 28.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.1 | 6.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
2.1 | 133.8 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
2.0 | 14.3 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
2.0 | 26.0 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
2.0 | 5.9 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
2.0 | 35.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
1.8 | 16.4 | GO:0097413 | Lewy body(GO:0097413) |
1.8 | 486.2 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
1.8 | 10.8 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
1.8 | 1.8 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.8 | 28.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.8 | 3.5 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
1.8 | 5.3 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
1.7 | 8.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.7 | 8.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.7 | 16.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
1.7 | 1.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
1.7 | 21.7 | GO:0005869 | dynactin complex(GO:0005869) |
1.6 | 3.3 | GO:0071203 | WASH complex(GO:0071203) |
1.6 | 6.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
1.6 | 11.0 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
1.6 | 11.0 | GO:0070852 | cell body fiber(GO:0070852) |
1.6 | 12.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.5 | 6.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
1.5 | 81.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.5 | 6.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
1.5 | 4.6 | GO:0034657 | GID complex(GO:0034657) |
1.5 | 32.2 | GO:0043198 | dendritic shaft(GO:0043198) |
1.5 | 47.3 | GO:0030175 | filopodium(GO:0030175) |
1.5 | 38.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.5 | 1.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.4 | 17.4 | GO:0008091 | spectrin(GO:0008091) |
1.4 | 182.9 | GO:0030426 | growth cone(GO:0030426) |
1.4 | 4.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.4 | 11.2 | GO:0033391 | chromatoid body(GO:0033391) |
1.4 | 2.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.4 | 8.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
1.4 | 5.5 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
1.4 | 1.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.3 | 27.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.3 | 18.9 | GO:0097227 | sperm annulus(GO:0097227) |
1.3 | 11.7 | GO:0031045 | dense core granule(GO:0031045) |
1.3 | 18.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.3 | 31.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.3 | 12.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.2 | 21.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.2 | 3.7 | GO:1902636 | kinociliary basal body(GO:1902636) |
1.2 | 3.7 | GO:0060187 | cell pole(GO:0060187) |
1.2 | 73.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.2 | 257.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
1.1 | 5.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
1.1 | 2.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
1.1 | 3.4 | GO:0036398 | TCR signalosome(GO:0036398) |
1.1 | 7.9 | GO:0072487 | MSL complex(GO:0072487) |
1.1 | 4.5 | GO:0016939 | kinesin II complex(GO:0016939) |
1.1 | 12.4 | GO:0005614 | interstitial matrix(GO:0005614) |
1.1 | 1.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.1 | 1.1 | GO:0000502 | proteasome complex(GO:0000502) |
1.1 | 2.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
1.1 | 6.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
1.1 | 50.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
1.1 | 5.3 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
1.1 | 7.4 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
1.0 | 4.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.0 | 6.0 | GO:0032009 | early phagosome(GO:0032009) |
1.0 | 3.0 | GO:0016013 | syntrophin complex(GO:0016013) |
1.0 | 71.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
1.0 | 1.9 | GO:0033270 | paranode region of axon(GO:0033270) |
1.0 | 1.9 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.9 | 4.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.9 | 15.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.9 | 27.5 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.9 | 5.4 | GO:0060076 | excitatory synapse(GO:0060076) |
0.9 | 4.5 | GO:0016342 | catenin complex(GO:0016342) |
0.9 | 16.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.9 | 13.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.9 | 0.9 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.9 | 1.7 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.9 | 12.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.9 | 12.0 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.8 | 10.2 | GO:0000145 | exocyst(GO:0000145) |
0.8 | 5.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.8 | 5.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.8 | 4.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.8 | 48.3 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.8 | 4.1 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.8 | 8.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.8 | 5.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.8 | 14.4 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.8 | 58.6 | GO:0043204 | perikaryon(GO:0043204) |
0.8 | 3.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.8 | 2.4 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.8 | 32.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.8 | 29.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.8 | 2.3 | GO:0032059 | bleb(GO:0032059) |
0.8 | 3.8 | GO:0030427 | site of polarized growth(GO:0030427) |
0.8 | 9.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.8 | 6.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.8 | 7.7 | GO:0099568 | cytoplasmic region(GO:0099568) |
0.8 | 4.6 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.8 | 6.0 | GO:0033010 | paranodal junction(GO:0033010) |
0.7 | 2.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.7 | 2.9 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.7 | 17.4 | GO:0014704 | intercalated disc(GO:0014704) |
0.7 | 43.1 | GO:0005776 | autophagosome(GO:0005776) |
0.7 | 12.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.7 | 1.4 | GO:0043196 | varicosity(GO:0043196) |
0.7 | 6.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.7 | 4.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.7 | 33.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.7 | 4.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.7 | 2.1 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.7 | 2.7 | GO:0032437 | cuticular plate(GO:0032437) |
0.7 | 64.7 | GO:0005814 | centriole(GO:0005814) |
0.7 | 8.2 | GO:0030018 | Z disc(GO:0030018) |
0.7 | 3.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.7 | 42.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.7 | 2.7 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.7 | 2.0 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.7 | 21.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.7 | 2.0 | GO:0071745 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.6 | 3.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.6 | 10.3 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.6 | 3.2 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.6 | 9.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 12.3 | GO:0005921 | gap junction(GO:0005921) |
0.6 | 42.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.6 | 8.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.6 | 3.0 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.6 | 2.4 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.6 | 54.7 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.6 | 31.0 | GO:0005770 | late endosome(GO:0005770) |
0.6 | 1.7 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.6 | 3.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.6 | 1.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.6 | 317.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.6 | 6.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.6 | 13.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.6 | 1.7 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.6 | 2.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.6 | 1.7 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.6 | 14.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.6 | 101.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.5 | 1.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.5 | 8.5 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.5 | 31.7 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.5 | 2.6 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.5 | 10.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.5 | 11.5 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.5 | 2.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.5 | 9.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.5 | 31.3 | GO:0030496 | midbody(GO:0030496) |
0.5 | 5.0 | GO:0070187 | telosome(GO:0070187) |
0.5 | 0.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.5 | 52.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.5 | 2.0 | GO:0070695 | FHF complex(GO:0070695) |
0.5 | 1.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 31.1 | GO:0030133 | transport vesicle(GO:0030133) |
0.5 | 43.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.5 | 6.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.5 | 2.9 | GO:0051233 | spindle midzone(GO:0051233) |
0.5 | 4.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 10.4 | GO:0031982 | vesicle(GO:0031982) |
0.5 | 7.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 2.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.5 | 63.0 | GO:0043209 | myelin sheath(GO:0043209) |
0.5 | 14.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 59.7 | GO:0010008 | endosome membrane(GO:0010008) |
0.4 | 113.0 | GO:0005874 | microtubule(GO:0005874) |
0.4 | 1.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.4 | 6.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 1.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.4 | 14.6 | GO:0098793 | presynapse(GO:0098793) |
0.4 | 0.4 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.4 | 0.4 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.4 | 1.2 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.4 | 5.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 1.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.4 | 1.6 | GO:0019867 | outer membrane(GO:0019867) |
0.4 | 8.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 1.9 | GO:0089701 | U2AF(GO:0089701) |
0.4 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
0.4 | 2.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 0.4 | GO:0005773 | vacuole(GO:0005773) |
0.4 | 10.2 | GO:0005903 | brush border(GO:0005903) |
0.4 | 0.7 | GO:0072687 | meiotic spindle(GO:0072687) |
0.4 | 1.4 | GO:0045177 | apical part of cell(GO:0045177) |
0.3 | 25.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.3 | 46.9 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.3 | 0.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.3 | 1.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 5.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 1.9 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.3 | 1.0 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.3 | 1.0 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.3 | 1.6 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 15.2 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.3 | 2.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 2.1 | GO:0097361 | CIA complex(GO:0097361) |
0.3 | 0.9 | GO:0044447 | axoneme part(GO:0044447) |
0.3 | 5.4 | GO:0036126 | sperm flagellum(GO:0036126) |
0.3 | 1.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 33.5 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.3 | 0.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 55.7 | GO:0045202 | synapse(GO:0045202) |
0.3 | 3.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 0.3 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.3 | 1.0 | GO:0032044 | DSIF complex(GO:0032044) |
0.2 | 2.0 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 0.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.2 | 2.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.5 | GO:0002177 | manchette(GO:0002177) |
0.2 | 4.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 3.3 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 2.9 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 1.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 0.8 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.8 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.2 | 3.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 2.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 1.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 1.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 21.3 | GO:0016605 | PML body(GO:0016605) |
0.2 | 1.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 3.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 1.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.2 | 3.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.2 | 5.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.4 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 16.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.4 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
0.1 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 2.0 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 13.0 | GO:0031253 | cell projection membrane(GO:0031253) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 1.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 3.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 0.3 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.1 | 7.4 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.2 | GO:0000780 | condensed nuclear chromosome kinetochore(GO:0000778) condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 1.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 2.8 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 11.2 | GO:0030424 | axon(GO:0030424) |
0.1 | 2.4 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 8.2 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.4 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 5.1 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 2.5 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.1 | 2.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 4.4 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 1.0 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 1.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.3 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 1.1 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 1.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.7 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.6 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 2.2 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 1.6 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 3.3 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.1 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.0 | 0.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.4 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.7 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 10.7 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.1 | GO:0005602 | complement component C1 complex(GO:0005602) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.7 | 38.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
12.4 | 37.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
12.1 | 36.2 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
11.9 | 35.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
11.4 | 34.2 | GO:0052726 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
10.3 | 62.0 | GO:1903135 | cupric ion binding(GO:1903135) |
9.6 | 28.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
8.1 | 32.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
7.9 | 23.6 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
7.7 | 23.0 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
7.6 | 22.8 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
7.6 | 106.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
7.2 | 28.9 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
6.9 | 83.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
6.8 | 13.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
6.7 | 26.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
6.5 | 45.8 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
6.5 | 39.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
6.3 | 37.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
6.0 | 66.3 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
6.0 | 35.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
5.9 | 35.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
5.8 | 35.0 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
5.7 | 113.9 | GO:0050780 | dopamine receptor binding(GO:0050780) |
5.6 | 33.6 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
5.4 | 21.5 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
5.1 | 25.3 | GO:0070404 | NADH binding(GO:0070404) |
5.0 | 29.7 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
4.8 | 19.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
4.8 | 14.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
4.6 | 32.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
4.5 | 31.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
4.2 | 129.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
4.1 | 37.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
4.1 | 16.4 | GO:0099609 | microtubule lateral binding(GO:0099609) |
4.1 | 20.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
4.1 | 12.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
4.0 | 16.0 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
3.8 | 18.9 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
3.7 | 73.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
3.6 | 21.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
3.6 | 14.4 | GO:0035939 | microsatellite binding(GO:0035939) |
3.6 | 99.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
3.5 | 10.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
3.5 | 17.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
3.4 | 13.8 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
3.4 | 6.8 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
3.4 | 16.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
3.3 | 98.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
3.3 | 6.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
3.3 | 9.8 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
3.2 | 22.5 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
3.2 | 85.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
3.2 | 34.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
3.2 | 56.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
3.1 | 40.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
3.1 | 49.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
3.1 | 15.3 | GO:0016403 | dimethylargininase activity(GO:0016403) |
3.0 | 12.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
3.0 | 30.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
3.0 | 6.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
3.0 | 9.0 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
3.0 | 53.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
3.0 | 14.8 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
3.0 | 17.7 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
2.9 | 23.5 | GO:0004064 | arylesterase activity(GO:0004064) |
2.9 | 11.6 | GO:0043398 | HLH domain binding(GO:0043398) |
2.9 | 31.7 | GO:0048156 | tau protein binding(GO:0048156) |
2.9 | 17.2 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
2.9 | 17.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
2.9 | 11.4 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
2.8 | 8.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.8 | 11.3 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
2.8 | 55.0 | GO:0030955 | potassium ion binding(GO:0030955) |
2.7 | 8.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
2.7 | 27.1 | GO:0030911 | TPR domain binding(GO:0030911) |
2.7 | 10.7 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
2.7 | 23.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
2.6 | 118.6 | GO:0003785 | actin monomer binding(GO:0003785) |
2.6 | 49.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
2.6 | 28.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
2.6 | 13.0 | GO:0034046 | poly(G) binding(GO:0034046) |
2.6 | 12.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
2.5 | 7.6 | GO:0032427 | GBD domain binding(GO:0032427) |
2.5 | 43.1 | GO:0043495 | protein anchor(GO:0043495) |
2.5 | 73.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
2.5 | 22.7 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
2.5 | 25.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.5 | 10.0 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
2.5 | 2.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.5 | 37.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
2.5 | 24.8 | GO:1903136 | cuprous ion binding(GO:1903136) |
2.5 | 19.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
2.5 | 9.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
2.5 | 4.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.4 | 2.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
2.4 | 11.9 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
2.4 | 59.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
2.4 | 40.2 | GO:0005522 | profilin binding(GO:0005522) |
2.4 | 35.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
2.4 | 18.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
2.3 | 7.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.3 | 16.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
2.3 | 16.4 | GO:0016015 | morphogen activity(GO:0016015) |
2.3 | 62.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
2.3 | 6.9 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
2.3 | 13.8 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
2.3 | 9.2 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
2.3 | 6.8 | GO:0070025 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
2.3 | 22.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
2.2 | 13.2 | GO:0034452 | dynactin binding(GO:0034452) |
2.2 | 8.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
2.2 | 17.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
2.2 | 159.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
2.1 | 34.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
2.1 | 15.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
2.1 | 47.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
2.1 | 6.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
2.1 | 35.8 | GO:0031005 | filamin binding(GO:0031005) |
2.1 | 10.5 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.1 | 8.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
2.1 | 10.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
2.1 | 26.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.1 | 6.2 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
2.0 | 16.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
2.0 | 14.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
2.0 | 24.4 | GO:0031386 | protein tag(GO:0031386) |
2.0 | 6.0 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
2.0 | 42.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
2.0 | 10.0 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
2.0 | 9.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
2.0 | 9.8 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
2.0 | 11.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.9 | 7.8 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
1.9 | 30.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.9 | 47.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.9 | 7.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.8 | 5.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.8 | 7.4 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
1.8 | 23.7 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
1.8 | 16.4 | GO:0030552 | cAMP binding(GO:0030552) |
1.8 | 5.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
1.8 | 9.1 | GO:0097016 | L27 domain binding(GO:0097016) |
1.8 | 18.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.8 | 49.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.8 | 3.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
1.8 | 7.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.8 | 5.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.8 | 5.4 | GO:0036317 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
1.8 | 8.9 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
1.8 | 5.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.8 | 35.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.7 | 5.2 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
1.7 | 1.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.7 | 50.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
1.7 | 8.6 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
1.7 | 71.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.7 | 5.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.7 | 10.0 | GO:0039552 | RIG-I binding(GO:0039552) |
1.7 | 3.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
1.6 | 4.8 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
1.6 | 4.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.6 | 7.9 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
1.6 | 6.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.6 | 7.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.6 | 10.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.6 | 4.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.6 | 45.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.5 | 10.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.5 | 4.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.5 | 21.5 | GO:0031489 | myosin V binding(GO:0031489) |
1.5 | 24.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.5 | 1.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.5 | 22.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
1.5 | 6.0 | GO:0097001 | ceramide binding(GO:0097001) |
1.5 | 3.0 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
1.5 | 21.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.5 | 12.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
1.5 | 26.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.5 | 14.9 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.5 | 16.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.5 | 4.4 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
1.4 | 101.1 | GO:0019003 | GDP binding(GO:0019003) |
1.4 | 7.1 | GO:0034432 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
1.4 | 4.3 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
1.4 | 11.3 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.4 | 1.4 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
1.4 | 4.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.4 | 8.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.4 | 5.4 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
1.4 | 29.7 | GO:0030506 | ankyrin binding(GO:0030506) |
1.4 | 5.4 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
1.4 | 4.1 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
1.3 | 5.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.3 | 5.2 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
1.3 | 3.9 | GO:0004103 | choline kinase activity(GO:0004103) |
1.3 | 7.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.3 | 21.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
1.3 | 2.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.2 | 1.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.2 | 2.5 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
1.2 | 7.4 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
1.2 | 3.7 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
1.2 | 9.8 | GO:0000182 | rDNA binding(GO:0000182) |
1.2 | 3.7 | GO:0070728 | leucine binding(GO:0070728) |
1.2 | 3.6 | GO:0033149 | FFAT motif binding(GO:0033149) |
1.2 | 3.6 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
1.2 | 14.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.2 | 47.1 | GO:0030507 | spectrin binding(GO:0030507) |
1.2 | 9.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.2 | 3.5 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
1.2 | 26.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.2 | 16.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.1 | 8.0 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
1.1 | 1.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
1.1 | 4.5 | GO:0015232 | heme transporter activity(GO:0015232) |
1.1 | 5.6 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
1.1 | 265.6 | GO:0003924 | GTPase activity(GO:0003924) |
1.1 | 14.1 | GO:0070840 | dynein complex binding(GO:0070840) |
1.1 | 45.3 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
1.1 | 9.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.1 | 4.3 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
1.1 | 24.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.1 | 3.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.1 | 160.6 | GO:0044325 | ion channel binding(GO:0044325) |
1.1 | 10.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.1 | 4.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.1 | 25.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.0 | 4.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.0 | 10.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.0 | 3.1 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
1.0 | 13.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.0 | 4.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.0 | 5.1 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
1.0 | 1.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.0 | 3.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.0 | 3.9 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
1.0 | 1.0 | GO:0031692 | alpha-1B adrenergic receptor binding(GO:0031692) |
1.0 | 42.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
1.0 | 4.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
1.0 | 42.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
1.0 | 8.7 | GO:0051425 | PTB domain binding(GO:0051425) |
1.0 | 3.8 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
1.0 | 17.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.9 | 2.8 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
0.9 | 10.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.9 | 9.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.9 | 2.8 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.9 | 18.2 | GO:0005521 | lamin binding(GO:0005521) |
0.9 | 5.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.9 | 2.7 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.9 | 2.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.9 | 7.9 | GO:0043426 | MRF binding(GO:0043426) |
0.9 | 25.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.9 | 5.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.9 | 31.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.9 | 2.6 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.9 | 4.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.8 | 4.2 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.8 | 9.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.8 | 5.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.8 | 1.7 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.8 | 5.0 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.8 | 8.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.8 | 3.3 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.8 | 22.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.8 | 4.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.8 | 16.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.8 | 1.6 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.8 | 2.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.8 | 1.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.8 | 23.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.8 | 21.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.8 | 3.9 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.8 | 21.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.8 | 34.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.8 | 4.6 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.8 | 4.6 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.8 | 5.3 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.8 | 2.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.8 | 3.0 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.8 | 5.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.8 | 17.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.8 | 3.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.7 | 1.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.7 | 17.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.7 | 9.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.7 | 11.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.7 | 31.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.7 | 5.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.7 | 11.5 | GO:0005112 | Notch binding(GO:0005112) |
0.7 | 97.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.7 | 13.6 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.7 | 1.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.7 | 0.7 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.7 | 7.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.7 | 5.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.7 | 12.8 | GO:0035198 | miRNA binding(GO:0035198) |
0.7 | 91.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.7 | 2.1 | GO:0034191 | apolipoprotein receptor binding(GO:0034190) apolipoprotein A-I receptor binding(GO:0034191) |
0.7 | 2.8 | GO:0017040 | ceramidase activity(GO:0017040) |
0.7 | 23.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.7 | 7.0 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.7 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.7 | 1.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.7 | 47.6 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.7 | 4.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.7 | 5.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.7 | 8.9 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.7 | 7.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.7 | 2.7 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.7 | 2.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.7 | 5.3 | GO:0019863 | IgE binding(GO:0019863) |
0.7 | 9.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.7 | 1.3 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.7 | 9.8 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.6 | 4.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.6 | 6.4 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.6 | 3.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.6 | 6.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.6 | 6.9 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.6 | 6.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.6 | 8.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.6 | 15.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.6 | 2.5 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.6 | 1.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.6 | 1.8 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.6 | 5.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 1.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.6 | 5.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.6 | 2.9 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.6 | 4.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.6 | 4.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.6 | 6.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.6 | 1.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.6 | 2.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.6 | 22.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.6 | 2.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.6 | 2.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.5 | 18.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.5 | 1.6 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.5 | 2.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.5 | 7.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.5 | 2.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.5 | 1.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.5 | 2.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
0.5 | 10.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.5 | 1.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.5 | 2.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.5 | 2.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.5 | 1.6 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
0.5 | 2.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.5 | 1.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) Toll-like receptor 2 binding(GO:0035663) |
0.5 | 3.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.5 | 6.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 3.0 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.5 | 10.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.5 | 2.0 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.5 | 1.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
0.5 | 5.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.5 | 3.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 182.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.5 | 4.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.5 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.5 | 2.9 | GO:1990405 | protein antigen binding(GO:1990405) |
0.5 | 1.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.5 | 3.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 0.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 4.3 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 0.9 | GO:0000035 | acyl binding(GO:0000035) |
0.5 | 49.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.5 | 3.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.5 | 3.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.5 | 48.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 2.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.5 | 11.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.5 | 28.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.5 | 0.5 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.4 | 28.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 2.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.4 | 2.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 0.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 14.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 1.3 | GO:0004775 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.4 | 38.2 | GO:0005525 | GTP binding(GO:0005525) |
0.4 | 2.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 54.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.4 | 1.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 0.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 1.6 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.4 | 13.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.4 | 2.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.4 | 2.0 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.4 | 1.2 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.4 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 0.8 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.4 | 8.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.4 | 3.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.4 | 0.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.4 | 0.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.4 | 1.5 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.4 | 1.5 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.4 | 17.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.4 | 22.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.4 | 10.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.4 | 1.1 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.4 | 8.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 1.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 0.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.4 | 1.5 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.4 | 2.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.4 | 1.8 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.4 | 3.6 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.4 | 0.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.4 | 1.1 | GO:0045174 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.4 | 2.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.4 | 10.2 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 0.7 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.3 | 1.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.3 | 1.0 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.3 | 0.3 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.3 | 5.8 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.3 | 1.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 5.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 29.0 | GO:0005516 | calmodulin binding(GO:0005516) |
0.3 | 1.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.2 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.3 | 0.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 1.5 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.3 | 9.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 1.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.3 | 0.9 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.3 | 1.5 | GO:0019239 | deaminase activity(GO:0019239) |
0.3 | 2.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 4.5 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.3 | 1.8 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.3 | 0.9 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.3 | 0.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 5.9 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.3 | 0.8 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.3 | 3.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 1.1 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.3 | 2.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.3 | 0.6 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.3 | 3.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.3 | 0.8 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.3 | 1.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 54.7 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.3 | 14.0 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.3 | 4.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.3 | 1.8 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.3 | 0.8 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 1.0 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
0.3 | 3.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.8 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 2.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 1.5 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.7 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.2 | 0.5 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.2 | 0.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 0.2 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.2 | 1.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 1.2 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.2 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 5.5 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.9 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.2 | 1.6 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.2 | 0.7 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.2 | 38.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.2 | 0.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.7 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 0.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.2 | 0.8 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 29.5 | GO:0003779 | actin binding(GO:0003779) |
0.2 | 0.6 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.2 | 1.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 0.2 | GO:0043532 | angiostatin binding(GO:0043532) |
0.2 | 0.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.8 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.2 | 1.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 1.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.4 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 2.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 0.8 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.2 | 0.6 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 2.6 | GO:0043295 | glutathione binding(GO:0043295) |
0.2 | 0.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 3.7 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.2 | 1.1 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.2 | 0.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 0.5 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.2 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 1.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 0.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 1.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 0.7 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.2 | 0.7 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.2 | 1.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 0.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 1.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 1.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 0.3 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.2 | 0.5 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.2 | 0.5 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.2 | 5.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.9 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.1 | 1.6 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.1 | 0.6 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.1 | 1.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 2.1 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.6 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.3 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 0.5 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 3.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.5 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.1 | 0.4 | GO:0004877 | complement component C4b binding(GO:0001855) complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
0.1 | 0.8 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.4 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 1.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.5 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 0.3 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.1 | 0.6 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.2 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
0.1 | 0.8 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.5 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
0.1 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.3 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.1 | 0.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.1 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.1 | 8.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.5 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 0.6 | GO:0052744 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.1 | 0.2 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 4.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 0.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.4 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 1.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 1.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.2 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.1 | 0.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.3 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.1 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.2 | GO:0008940 | nitrate reductase activity(GO:0008940) |
0.1 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 1.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.2 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
0.0 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.0 | 0.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.7 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.0 | 1.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.2 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.0 | 0.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 0.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.3 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 1.1 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.7 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.1 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.0 | 0.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 1.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.0 | 0.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.0 | 0.1 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.0 | 0.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.1 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.0 | 0.2 | GO:0030883 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) lipopeptide binding(GO:0071723) |
0.0 | 0.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.0 | 0.1 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.0 | 0.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 1.4 | GO:0005543 | phospholipid binding(GO:0005543) |
0.0 | 0.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.0 | GO:0030305 | heparanase activity(GO:0030305) |
0.0 | 0.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 93.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
4.2 | 171.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
3.3 | 20.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
3.0 | 51.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
3.0 | 106.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
2.9 | 158.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
2.7 | 16.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
2.7 | 27.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
2.6 | 34.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
2.4 | 94.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
2.4 | 4.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
2.2 | 13.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
2.0 | 60.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
2.0 | 137.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.8 | 132.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.6 | 40.4 | PID REELIN PATHWAY | Reelin signaling pathway |
1.5 | 56.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.5 | 88.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.4 | 2.9 | PID IFNG PATHWAY | IFN-gamma pathway |
1.4 | 26.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.3 | 68.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.2 | 62.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
1.2 | 27.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.2 | 38.7 | PID ARF6 PATHWAY | Arf6 signaling events |
1.1 | 55.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
1.0 | 44.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.9 | 16.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.9 | 4.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.8 | 8.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.8 | 11.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.8 | 9.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.8 | 17.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.8 | 27.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.7 | 25.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.7 | 45.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.7 | 15.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.7 | 80.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.7 | 14.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.6 | 3.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.6 | 13.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.6 | 32.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.6 | 3.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.6 | 6.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.6 | 16.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.6 | 51.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.5 | 11.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.5 | 36.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.5 | 2.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.5 | 1.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.5 | 21.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 3.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.5 | 12.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.5 | 18.0 | PID FGF PATHWAY | FGF signaling pathway |
0.5 | 23.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 18.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.5 | 9.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.5 | 9.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.5 | 1.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 3.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 3.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 13.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.4 | 3.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 83.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 2.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 2.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 6.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 1.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 3.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.3 | 1.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 9.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 3.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 1.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 6.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 1.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 6.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 4.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 4.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 4.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 3.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 4.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.3 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 1.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 2.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 3.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 2.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 2.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 2.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 4.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 1.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 81.2 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
5.5 | 99.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
4.9 | 97.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
4.1 | 199.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
4.1 | 32.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
4.0 | 109.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
4.0 | 110.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
3.8 | 19.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
3.4 | 167.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
3.3 | 46.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
3.0 | 163.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
3.0 | 84.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
2.9 | 77.9 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
2.8 | 50.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
2.8 | 80.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
2.4 | 85.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.4 | 7.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
2.3 | 25.8 | REACTOME OPSINS | Genes involved in Opsins |
2.3 | 29.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
2.3 | 76.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.1 | 23.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
2.0 | 40.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
2.0 | 34.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.9 | 85.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.9 | 40.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.9 | 41.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
1.8 | 18.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.7 | 19.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
1.6 | 50.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.6 | 19.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.6 | 48.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.6 | 25.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.6 | 20.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.5 | 50.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.5 | 13.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.5 | 29.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.5 | 16.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.4 | 168.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
1.4 | 5.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.4 | 13.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.4 | 4.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
1.3 | 5.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
1.2 | 196.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.1 | 21.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.1 | 17.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
1.1 | 42.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.1 | 5.4 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
1.1 | 5.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.1 | 16.8 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
1.0 | 21.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.0 | 15.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.0 | 5.1 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
1.0 | 11.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.0 | 41.6 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
1.0 | 1.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.0 | 14.7 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
1.0 | 23.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.0 | 21.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.0 | 34.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.0 | 3.9 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
1.0 | 17.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.9 | 11.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.9 | 7.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.9 | 20.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.9 | 10.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.9 | 16.4 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.9 | 46.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.9 | 24.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.8 | 16.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.8 | 19.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.8 | 7.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.8 | 29.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.7 | 64.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.7 | 29.0 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.7 | 13.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.7 | 22.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.7 | 7.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.7 | 2.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.6 | 8.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.6 | 5.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.6 | 5.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.6 | 2.9 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.6 | 18.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.5 | 4.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 17.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.5 | 6.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.5 | 24.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.5 | 3.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 3.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 1.8 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.5 | 1.8 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.4 | 9.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.4 | 3.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 20.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.4 | 9.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.4 | 3.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.4 | 9.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 0.4 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.4 | 8.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 0.7 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.3 | 2.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 26.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.3 | 2.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.3 | 4.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 6.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.3 | 5.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 2.8 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.3 | 2.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.3 | 3.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 26.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 1.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 4.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 21.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 4.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 3.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 13.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 31.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 4.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 5.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 6.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 6.2 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.2 | 2.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 1.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 3.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 1.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.5 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 1.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 3.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 1.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 3.5 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 2.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 3.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 2.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 1.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 4.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 1.4 | REACTOME PHOSPHOLIPID METABOLISM | Genes involved in Phospholipid metabolism |